A proposed FDA pathway could make it easier to evaluate personalized treatments for tiny patient groups that do not fit classic trial models. more...
Conflicting guidance on when screening should begin keeps turning a routine prevention decision into a confusing personal calculation. more...
Researchers say machine learning may help narrow down affordable compounds for conditions like MND instead of relying only on slower lab-first searches. more...
Human Verification
Please enter the characters shown in the image.
Enter the characters from the image to enable sending.